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ABSTRACT
The molecular role of poly (ADP-ribose) polymer-
ase-1 in DNA repair is unclear. Here, we show that
the single-strand break repair protein XRCC1 is
rapidly assembled into discrete nuclear foci after
oxidative DNA damage at sites of poly (ADP-ribose)
synthesis. Poly (ADP-ribose) synthesis peaks dur-
ing a 10 min treatment with H2O2 and the appear-
ance of XRCC1 foci peaks shortly afterwards. Both
sites of poly (ADP-ribose) and XRCC1 foci decrease
to background levels during subsequent incubation
in drug-free medium, consistent with the rapidity of
the single-strand break repair process. The forma-
tion of XRCC1 foci at sites of poly (ADP-ribose) was
greatly reduced by mutation of the XRCC1 BRCT I
domain that physically interacts with PARP-1.
Moreover, we failed to detect XRCC1 foci in
Adprt1±/± MEFs after treatment with H2O2. These
data demonstrate that PARP-1 is required for the
assembly or stability of XRCC1 nuclear foci after
oxidative DNA damage and suggest that the forma-
tion of these foci is mediated via interaction with
poly (ADP-ribose). These results support a model in
which the rapid activation of PARP-1 at sites of DNA
strand breakage facilitates DNA repair by recruiting
the molecular scaffold protein, XRCC1.
INTRODUCTION
Single-strand breaks (SSBs) can arise directly (e.g. by
fragmentation of damaged deoxyribose) or indirectly (e.g.
during the enzymatic excision of abasic sites) (1,2). The
importance of repairing SSBs is suggested by the increased
spontaneous and/or induced genetic instability of cell lines in
which polypeptide components of this process are absent or
mutated (3±7). It is likely that, if not repaired, SSBs are
converted into DSBs during DNA replication (8).
A critical component of SSBR is the polypeptide XRCC1.
Mutant cell lines lacking XRCC1 display hypersensitivity to a
broad range of genotoxins, increased frequencies of trans-
locations and deletions, and a reduced ability to rapidly repair
chromosomal SSBs (9). Mice with targeted disruption of both
Xrcc1 alleles exhibit early embryonic lethality (10). At the
molecular level, XRCC1 appears to coordinate or stimulate
enzymatic components of SSBR by physical interaction
(2,11). XRCC1 interacts with APE1 (12), DNA polymerase
b (13,14), DNA polynucleotide kinase(11), and DNA ligase
IIIa (15±18). In addition, XRCC1 also interacts with poly
(ADP-ribose) polymerase-1 (PARP-1) (13,19).
PARP-1 rapidly binds to DNA strand breaks (SSBs) and is
thereby activated, covalently automodifying itself and, to a
lesser extent, proximal acceptor proteins with poly (ADP-
ribose) polymer (PAR) (20,21). XRCC1 preferentially inter-
acts with automodi®ed PARP-1, most likely via a PAR-
binding motif present within the internal BRCT I domain of
XRCC1 (19,22). Consistent with this, inhibiting PAR synthe-
sis with 3-aminobenzamide greatly reduces or ablates the
interaction of XRCC1 with PARP-1 (23,24). These data have
prompted the hypothesis that one function of PARP-1 is to
recruit XRCC1 to sites of SSBs. In agreement with this, the
XRCC1 BRCT I domain is critical for SSBR and for cell
survival mediated by XRCC1 after DNA alkylation (25).
However, evidence that PARP-1 might recruit XRCC1 to
SSBs is currently lacking.
Here, we have addressed the spatial and temporal relation-
ship between PAR synthesis and the assembly of XRCC1
subnuclear foci during the repair of oxidative SSBs induced by
H2O2. We show that H2O2 induces the rapid and transient
formation of PAR nuclear foci, indicative of the binding and
activation of PARP-1 at DNA strand breaks, followed soon
after by the appearance of XRCC1 nuclear foci at the same
sites. Mutation of the XRCC1 BRCT I domain that interacts
with PAR reduces or prevents the appearance of XRCC1 foci,
and XRCC1 foci fail to appear after H2O2 in mouse cells
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harbouring a targeted disruption of the Adprt1 gene encoding
Parp-1. These data provide evidence that PARP-1 is required
for the recruitment of XRCC1 to sites of chromosomal DNA
strand breakage.
MATERIALS AND METHODS
Cells and cell culture
CHO cells were cultured as monolayers in a-MEM (Gibco,
Invitrogen Corporation) supplemented with 10% fetal calf
serum (Gibco). The expression constructs empty pcD2E,
pcD2E-XH, pcD2E-XHC389A, or pcD2E242±533 were trans-
fected into EM9 cells by calcium phosphate coprecipitation
and pooled populations of >50 transfectants were selected in
the presence of G418 (1.5 mg/ml) for 10±14 days, creating
the cell lines EM9-V, EM9-XH, EM9-XHC389A and EM9-
XH242±533, respectively. The cell lines EM9-XHR399Q, EM9-
XHW385D, EM9-XHLI360/361DD and the wild-type control cell
lines for the latter two mutants (EM9-XH5) have been
described previously (25). Spontaneously immortalized
Adprt1+/+ and Adprt1±/± mouse embryonic ®broblasts (26)
were cultured as monolayers in DMEM (Gibco) supplemented
with 10% fetal calf serum.
Expression constructs
The mammalian cell expression vector pcD2E and the
derivative pcD2EXH encoding C-terminally histidine-tagged
XRCC1 (XRCC1-His) have been described previously
(17,27). Oligonucleotide primers (Forward; 5¢-CCCGAATT-
CGTTGACATGCACCATCACCATCACCATGGGATCCC-
CAAAGGGAAGAGGAAGTTG-3¢ and Reverse; 5¢-CCCG-
AATTCTGCAGTCAATCAGGAGGCTCCTGGTGTTC-3¢)
were used to amplify XRCC1242±533 using PCR. The PCR
product was cloned into pCR2.1 TOPO vector (Invitrogen),
con®rmed by sequencing, and the XRCC1242±533 ORF
subcloned into the EcoR1 site of pcD2E. Derivatives of
pcD2EXH harbouring mutations within the BRCT I domain
were described previously (25).
Indirect immuno¯uorescence
Cells were grown on coverslips, rinsed in PBS, and treated
with either 10 mM H2O2 in PBS at room temperature for
20 min, or with 20 or 40 mg/ml MMS for 20 min at 37°C.
Rinsed coverslips were then incubated for the indicated times
in drug-free medium at 37°C. Coverslips were rinsed in PBS
and ®xed with methanol±acetone (1:1, v/v) for 10 min at 4°C.
Fixed cells were rinsed in PBS and permeabilized for 5 min at
4°C in 20 mM HEPES, pH 7.4, 50 mM NaCl, 3 mM MgCl2,
300 mM sucrose, 0.5% Triton X-100. Permeabilized cells
were rinsed in PBS and incubated for 20 min at 37°C with
either anti-phospho H2AX monoclonal antibody (Upstate;
clone JBW301, 1/800 dilution) or a mixture of anti-poly
(ADP-ribose) monoclonal antibodies (10H; a gift from Gilbert
de Murcia, 1:200 dilution in PBS supplemented with 2%
bovine serum albumin, fraction V, Sigma) and anti-XRCC1
polyclonal antibodies (AHP428, Serotec, 1:200 dilution as
above). After rinsing in PBS, coverslips were incubated in a
mixture of either ¯uorescein isothiocyanate-conjugated
anti-mouse IgG (DAKO) secondary antibody, or a mixture
of ¯uorescein isothiocyanate-conjugated anti-rabbit IgG
(DAKO) and TRITC-conjugated anti-mouse IgG (Sigma)
secondary antibodies, at 1:200 dilution in PBS supplemented
with 2% bovine serum albumin, fraction V for 20 min at 37°C.
Nuclei were counterstained with 0.000025% 4¢,6¢-diamidino-
2-phenylindole (DAPI). Cells were analysed and photo-
graphed with a Zeiss Axioplan-2 ¯uorescence microscope
equipped with a model RTI/CCD-1300/Y chilled
charge-coupled device digital camera (Princeton, NJ) and
Metamorph imaging software. Photographs were taken at
1003 magni®cation.
Survival curves
CHO cells or MEFs (250±1000) were plated in 10-cm dishes
in duplicate and exposed to the indicated concentrations of
H2O2 for 10 min in PBS, or MMS for 20 min in complete
medium, at 37°C. Cells were washed with PBS (33) and then
incubated for 7±10 days in drug-free medium to form
macroscopic colonies. The surviving fraction was calculated
by dividing the average number of colonies on treated plates
by the average number on untreated plates. For each survival
curve, data are the mean (61 S.D.) of three independent
experiments.
Cell extracts and immunoblotting
Whole-cell extracts were prepared from frozen pellets of
transfected EM9 cells (2 3 106) or MEFs (6 3 105) by
resuspension in 0.2 ml of hot 23 Laemmli SDS±PAGE
loading buffer [100 mM Tris±Cl (pH 6.8), 4% SDS, 0.2%
Bromophenol Blue, 20% glycerol, 200 mM b-mercapto-
ethanol]. High-molecular-weight DNA was sheared by pas-
sage through a narrow-gauge needle and solubilized proteins
fractionated by SDS±PAGE and transferred to Nitrocellulose.
Filters were rinsed with TBST (25 mM Tris±HCl, 0.5 M NaCl,
0.1% Tween-20), blocked in TBST containing 5% non-fat
dried milk, and incubated for 1 h at room temperature with
anti-XRCC1 polyclonal antibody (AHP428, Serotec, 1:3000
dilution in TBST supplemented with 1% milk) or anti-Actin
monoclonal antibody (clone AC-40, Sigma, 1:1000 dilution).
Filters were washed in TBST (3 3 15 min) and incubated with
HRP-conjugated rabbit IgG (DAKO, 1:5000 dilution) or HRP-
conjugated mouse IgG (DAKO, 1:5000 dilution) for 1 h at
room temperature. Filters were washed in TBST (4 3 15 min)
and subject to chemiluminescence detection (Amersham
Biosciences).
RESULTS
To examine whether XRCC1 is recruited to sites of poly
(ADP-ribose) (PAR) synthesis at single-strand breaks induced
by DNA oxidation, immuno¯uorescence experiments were
conducted in CHO cells treated with H2O2. The CHO cells
employed were XRCC1-mutant EM9 cells harbouring either
empty pCD2E vector (EM9-V cells) or vector encoding
human histidine-tagged XRCC1 (EM9-XH cells). The two
cell lines were examined for co-localization of XRCC1 and
PAR before and after a 20 min treatment with 10 mM H2O2.
Immunostaining with anti-PAR Mabs revealed discrete
nuclear foci in both EM9-V and EM9-XH cells after H2O2
treatment and these foci were absent from untreated cells,
consistent with the rapid activation of PARP at H2O2-induced
SSBs (Fig. 1, red). XRCC1 was similarly detected as nuclear
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immunofoci after H2O2 treatment, a large proportion of which
co-localized with those of PAR (Fig. 1, green and `merge'). As
expected, XRCC1 signal was absent from EM9-V cells
harbouring empty vector (Fig. 1 bottom right panel). Next,
the kinetics at which PAR and XRCC1 foci were formed
during a 2-h repair-incubation after H2O2 treatment was
examined. The appearance of PAR foci in EM9-XH cells was
very rapid, peaking during the 20-min incubation with drug,
after which the number of foci-positive cells fell to back-
ground within 1 h (Fig. 2A, ®lled squares). The appearance of
XRCC1 foci displayed similar kinetics, though these foci
peaked a little later, after ~10 min of repair-incubation, and
persisted longer (Fig. 2A, open squares). The rapid and
transient formation of PAR and XRCC1 foci is consistent with
the kinetics of the rapid SSBR process.
The observation that XRCC1 foci appeared with slightly
delayed kinetics when compared to those of PAR is consistent
with the hypothesis that PARP-1 binds DNA strand breaks and
is activated, and then recruits XRCC1 to those breaks to
facilitate repair. To test whether the formation of XRCC1 foci
may re¯ect the recruitment of XRCC1 by PAR, we examined
the formation of XRCC1 foci in EM9-XHC389A cells express-
ing XRCC1 with a mutated BRCT I domain. The kinetics with
which PAR foci appeared and disappeared in EM9-XHC389A
cells was similar to that in EM9-XH cells (Fig. 2A, compare
®lled squares and ®lled circles). In contrast, the appearance of
XRCC1 foci in EM9-XHC389A cells in response to H2O2 was
reduced in comparison to EM9-XH cells, as measured by the
number of foci-positive cells (cells with >6 foci) observed at
different times during the repair incubation (Fig. 2A, compare
open circles and open squares). The reduced appearance of
XRCC1 foci in EM9-XHC389A cells was not explained by
lower levels of XRCC1 protein because this mutant cell line
exhibited slightly higher levels of XRCC1 than did EM9-XH
cells (see later, Fig. 3C).
EM9-XHC389A cells were only slightly more sensitive to
MMS and H2O2 than were EM9-XH cells (Fig. 2B). This
small effect on survival is in contrast to two other mutations in
BRCT I domain that we have examined previously, including
one mutation located only four amino acids from C389, which
entirely prevents the ability of XRCC1 to maintain cell
survival after MMS (25). We therefore examined the impact of
these additional BRCT I mutations on assembly of XRCC1
foci. One of the mutations is a double substitution of Leu360/
Ileu361 with two Asp residues and the second is a single
substitution of Trp385 with Asp (Fig. 3A). Similar to C389,
Trp385 lies within the PAR binding motif (22), and mutation
of Leu360 has previously been reported to prevent the
interaction between XRCC1 and PARP-1 (28). The appear-
ance of XRCC1 nuclear foci was reduced in both EM9-
XHLI360/361DD and EM9-XHW385D cells after H2O2 (Fig. 3B).
EM9-XHW385D cells exhibited the greatest reduction, with
~10-fold fewer XRCC1 foci observed 10 min after H2O2
treatment than was observed in wild-type EM9-XH5 cells. In
Figure 1. Co-localization of XRCC1 foci at sites of poly (ADP-ribose) synthesis after oxidative DNA damage. EM9 CHO cells expressing either human
XRCC1 (EM9-XH) or harbouring empty vector (EM9-V) were mock-treated (±H2O2) or treated with 10 mM H2O2 for 20 min and then incubated in drug-free
medium for 10 min. Untreated and treated cells were then ®xed with methanol/acetone and immunostained with anti-poly (ADP-ribose) (`PAR') monoclonal
antibody 10H and anti-XRCC1 polyclonal antibody (AHP428, Serotec) for analysis by indirect immuno¯uorescence. Representative images (3100 magni®ca-
tion) were photographed and coloured using an RTI/CCD-1300/Y digital camera and Metamorph software.
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contrast to the LI360/361DD and W385D mutations, a
naturally occurring human polymorphism (XRCC1 399Q)
located at the very end of the BRCT I domain did not
measurably affect the appearance of XRCC1 foci (Fig. 3B).
This is consistent with our previous observation that this
polymorphism does not measurably impact on SSBR in CHO
cells (25).
The BRCT I domain and the linker located between this
domain and the C-terminal BRCT II domain are the most
evolutionary conserved regions of XRCC1 (25). Indeed, a
putative homologue in Arabidopsis thaliana is comprised of
just these domains. We therefore expressed a human equiva-
lent of the A.thaliana XRCC1, encoding residues 242±533
(see Fig. 3A and C), to examine whether these two
evolutionary conserved domains are suf®cient to allow
assembly of human XRCC1 into nuclear foci. Interestingly,
EM9-XH242±533 cells exhibited high levels of XRCC1 foci
even in the absence of H2O2, though an increase in foci-
positive cells was observed after H2O2 (Fig. 3B). The BRCT I
domain and the linker region located downstream of this
domain are thus suf®cient for assembly of XRCC1 in
subnuclear foci, though other domains of XRCC1 may be
important to regulate this process. Perhaps consistent with
Figure 2. Temporal assembly of PAR foci and XRCC1 foci in EM9 CHO
cells expressing wild-type human XRCC1 or XRCC1C389A. (A) EM9-XH
cells (squares) or EM9-XHC389A cells (circles) were mock-treated (`no
damage') or treated with 10 mM H2O2 for 20 min and then incubated for 0,
10, 30, 60 or 120 min as indicated (`R0-R120') in drug-free medium to
allow time for repair. Cells were then ®xed and immunostained with anti-
PAR antibodies (solid lines) and anti-XRCC1 antibodies (dotted lines) as
described for Figure 1. For each time point, 100 cells were scored for the
presence of six or more foci per cell. Data points are the mean of two or
three experiments and error bars represent the data range or 1 S.D. from the
mean (R10), respectively. Where not visible, error bars are smaller than the
symbols. (B) 250 cells of the indicated cell lines were plated in 10 cm
dishes in duplicate and either mock-treated or treated with the indicated
concentrations of H2O2 for 10 min or MMS for 1 h. Cells were then rinsed
in PBS and incubated in drug-free medium for 7±10 days to allow formation
of macroscopic colonies. Survival was calculated by dividing the average
number of colonies on treated plates by the average number on untreated
plates. Data are the mean of three independent experiments for each drug
and error bars represent 61 S.D. Where not visible, error bars are smaller
than the symbols.
Figure 3. The BRCT I domain is required for appearance of XRCC1
nuclear foci after oxidative DNA damage. (A) Schematic of full-length
XRCC1 (top) and XRCC1242±533 (bottom) depicting the proposed PAR-
binding motif (dotted box) located within BRCT I domain. The position of
the nuclear localization signal (NLS) and of the mutations employed in this
study are shown. (B) Mutation of the BRCT I domain inhibits assembly of
XRCC1 nuclear foci after H2O2 treatment. The indicated cell lines were
mock-treated (`±') or treated (`+') with H2O2 for 20 min, incubated in drug-
free medium for 10 min, and then processed for anti-XRCC1 immuno-
¯uorescence as described for Figure 1. 100 cells from each cell line were
scored for the presence or absence of six or more foci. Each data point rep-
resents the mean of two independent experiments and error bars re¯ect the
data range. EM9-XH5 is a single transfectant clone and is the wild-type
control for EM9-XHLI360/361DD and EM9-XHW385D, with which it expresses
similar levels of recombinant human XRCC1 (25). EM9-XH is a pooled
population of more than 50 transfectants and is the control cell line for
EM9-XH242±533 and EM9-XHR399Q (25). (C) XRCC1 protein levels in EM9-
V, EM9-XH, EM9-XH242±533 and EM9-XHC389A cells. Protein extracts from
the indicated cell lines were fractionated by SDS±PAGE, transferred to
nitrocellulose and immunoblotted with anti-XRCC1 polyclonal antibody.
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this, XRCC1242±533 failed to correct the sensitivity of EM9
cells to either H2O2 or MMS (Fig. 2B, open squares).
If PARP-1 activity is required to recruit XRCC1 to sites of
SSBs, then XRCC1 should fail to assemble into foci in cells
lacking PARP-1. We therefore examined the formation of
Xrcc1 foci in MEFs harbouring targeted disruption of exon 1
of the Adprt-1 gene (from here on termed Parp1 for clarity)
that encodes Parp-1 (26). As expected, immunostaining with
anti-PAR antibodies revealed nuclear foci in Parp1+/+ MEFs
after H2O2, but few or no foci in Parp1+/+ MEFs before H2O2
or in Parp1±/± MEFs after H2O2 (Fig. 4, red). Similarly, Xrcc1
foci formed in Parp1+/+ MEFs after H2O2, and many of these
co-localized with PAR (Fig. 4, green). Typically, we observed
between 10 and 30 Xrcc1/PAR foci per cell. Strikingly,
however, Xrcc1 nuclear foci were not detected in Parp1±/±
cells after H2O2, demonstrating that PARP-1 is required for
the appearance of Xrcc1 foci after exposure to this drug.
Although the dose of H2O2 employed in these experiments
(10 mM) is lethal, similar numbers of Xrcc1 foci-positive cells
were observed at lower, more physiological, doses of H2O2 in
Parp1+/+ cells (Fig. 5A and B). Once again, between 10 and 30
foci were typically observed per cell, and these foci were both
similar in appearance to those observed after 10 mM H2O2 and
were similarly co-localized with sites of PAR (data not
shown). The absence of Xrcc1 foci did not re¯ect an impact of
PARP-1 on Xrcc1 protein levels because Xrcc1 was present at
similar levels in Parp1+/+ and Parp1±/± cell extracts, both
before and after H2O2 treatment (Fig. 5C).
Similar results were observed when the response of
Parp1+/+ and Parp1±/± cells to the alkylating agent methyl
methanesulphonate (MMS) was examined. Whereas most
Parp1+/+ cells exhibited Xrcc1 and PAR foci that co-localized
extensively after exposure to physiological doses of MMS,
Parp1±/± cells did not (Fig. 6A and B). Finally, to rule out the
possibility that the Parp1±/± MEFs employed here were unable
to mount any response to DNA damage under the conditions
employed, we compared these cells with Parp1+/+ MEFs for
the appearance of phospho H2AX foci, an early event
triggered in response to DNA strand breaks. In contrast to
XRCC1 foci, the appearance of H2AX foci was observed in
Figure 5. XRCC1 protein levels, nuclear foci and survival to H2O2 in
Parp1+/+ or Parp1±/± MEFs. (A) Parp1+/+ MEFs were treated for 20 min
with the indicated concentrations of H2O2 and then incubated in drug-free
medium for 10 min. Cells were immunostained for Xrcc1 and PAR as
described in Figure 4 and the fraction of cells with >6 Xrcc1 foci was deter-
mined. The absence of visible bars for untreated cells indicates the absence
of detectable foci-positive cells. Data are the mean of duplicate samples
from a single experiment, and the data range for each duplicate was less
than ®ve. (B) The clonogenic survival of Parp1+/+ or Parp1±/± MEFs treated
with the indicated concentrations of H2O2 was determined as described in
Figure 2B. (C) Protein extracts from mock-treated or H2O2-treated Parp1+/+
or Parp1±/± MEFs were fractionated by SDS±PAGE, transferred to nitro-
cellulose and immunoblotted with anti-XRCC1 polyclonal, or anti-actin
monoclonal, antibody.
Figure 4. PARP-1 is required for appearance of XRCC1 nuclear foci at
sites of oxidative DNA damage. Parp1+/+ or Parp1±/± MEFs were mock-
treated or treated for 20 min with 10 mM H2O2 and then incubated in drug-
free medium for 10 min. Cells were then ®xed in methanol/acetone and
processed for indirect immuno¯uorescence using anti-PAR monoclonal anti-
body and anti-XRCC1 polyclonal antibody and counterstained with DAPI.
Representative cells are shown (3100 magni®cation).
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both Parp1+/+ and Parp1±/± cells, after exposure to 10 mM
H2O2 (Fig. 6C).
DISCUSSION
The phenotype of cells in which PARP-1 is inhibited or absent
is consistent with a role in DNA repair (21,29,30), but the
nature of this role is unclear. A direct physical link between
PARP-1 and the DNA strand break repair machinery emerged
with the discovery that PARP-1 interacts with the BRCT I
domain of XRCC1 (13,19). XRCC1 appears to operate as a
molecular scaffold protein that interacts with and stimulates
enzymatic components of single strand break repair (2,31). In
this study, we have shown that PARP-1 is required for the
rapid appearance of XRCC1 nuclear foci after oxidative
damage and that these foci co-localize with sites of PAR
synthesis. PAR synthesis was the product of PARP-1 activity
because it was absent from MEFs in which Parp-1 was
disrupted. The appearance of XRCC1 foci was dependent
upon the central BRCT I domain in this polypeptide, which
has been shown previously to interact with PAR polymer and
to be critical for the role of XRCC1 in SSBR and for cell
survival (22,25).
What are the nature of the breaks at which PARP-1 and
XRCC1 foci assemble? Given the extensive involvement of
XRCC1 in SSBR (2,31), it seems likely that SSBs are
responsible for the foci observed after H2O2, though an
involvement of DSBs is possible (32). It is likely that the
XRCC1/PAR foci reported here are physiologically relevant
sites of DNA strand break repair because they rapidly
disappeared during a repair incubation in drug-free medium.
These foci could re¯ect the steady state number of DNA strand
Figure 6. XRCC1 and H2AX nuclear foci in Parp1+/+ and Parp1±/± MEFs following exposure to MMS and H2O2. (A) Parp1+/+ (`+/+') and Parp1±/± (`±/±')
MEFs were treated for 20 min with the indicated concentrations of MMS and then incubated in drug-free medium for 10 min. Cells were immunostained for
Xrcc1 and PAR as described in Figure 4 and the fraction of cells with >6 Xrcc1 foci was determined. The absence of visible bars for untreated cells and for
treated Parp1±/± MEFs indicates the absence of detectable foci-positive cells. Data are the mean of duplicate samples from a single experiment, and the data
range for each duplicate was less than ®ve. (B) The clonogenic survival of Parp1+/+ or Parp1±/± MEFs treated with the indicated concentrations of MMS for
1 h was determined as described in Figure 2B. Where not visible, error bars are smaller than the symbols. (C) Parp1+/+ or Parp1±/± MEFs were mock-treated
or treated for 20 min with 10 mM H2O2 as indicated and then incubated in drug-free medium for 10 min. Cells were then ®xed in methanol/acetone and pro-
cessed for indirect immuno¯uorescence using anti-phospho H2AX monoclonal antibody (Upstate; clone JBW301) and counterstained with DAPI.
Representative cells are shown (3100 magni®cation).
Nucleic Acids Research, 2003, Vol. 31, No. 19 5531
 at U






breaks undergoing repair at the time of ®xation, or alterna-
tively could re¯ect a discrete number of `repair factories' into
which DNA strand breaks are recruited.
XRCC1 is required for at least two types of SSBR process, a
rapid pathway that occurs throughout the cell cycle and a
second pathway that is speci®c for S/G2 phase (33). In
addition, there exists at least one additional SSBR pathway
that is XRCC1 independent. Of the two identi®ed XRCC1-
dependent processes, the S/G2 pathway appears to be the most
important for cell survival. Indeed, the S/G2 process can
largely compensate for absence of the rapid pathway, possibly
by removing unrepaired SSBs when they are encountered by
the replication fork (33,34). It is unclear whether the XRCC1/
PAR foci observed here are associated with one or both of
these processes, though the rapid appearance of PAR foci and
XRCC1 foci correlates best with the rapid pathway.
The requirement for PARP-1 for assembly of XRCC1 foci
could be direct, via the ability of these polypeptides to interact.
Alternatively, it could re¯ect an indirect impact of PARP-1 on
the expression of other repair genes or on chromatin archi-
tecture (35±37). However, we favour the model that PARP-1
directly recruits XRCC1 via the binding of PAR polymer to
XRCC1, for several reasons. First, XRCC1 interacts prefer-
entially with ribosylated PARP-1 and XRCC1 binds puri®ed
PAR polymer in vitro (19,22±24). This strongly suggests that
PARP-1 recruits XRCC1 by physical interaction once PAR
synthesis is triggered at a DNA strand break. Second, the
interaction of XRCC1 with PAR polymer occurs via a motif
within the BRCT I domain, mutations within which reduced
the formation of XRCC1 foci after oxidative DNA damage.
Also, a truncated XRCC1 polypeptide encoding just the BRCT
I domain and the linker domain between BRCT I and BRCT II
was able to form XRCC1 foci, albeit in an apparently
deregulated fashion that may not be responsive to oxidative
DNA damage. The difference observed in the impact of the
three mutations on foci formation may be due to leakiness,
since there is a high degree of redundancy amongst PAR-
binding motifs (22). The LI360/361DD and W385D mutations
had the greatest effect on foci formation, reducing their
appearance by ~3- and 10-fold, respectively. These mutations
appear to impact speci®cally on functions of the BRCT I
domain because we have shown previously that they do not
prevent protein±protein interactions mediated by ¯anking
domains (25). Together, these data best support a model in
which PARP-1 mediates the assembly of XRCC1 foci after
oxidative DNA damage by direct interaction of the XRCC1
BRCT I domain with PAR polymer, thereby recruiting
XRCC1 to sites of DNA strand breakage.
A requirement for PARP-1 for recruiting XRCC1 to strand
breaks during DNA repair reactions in vitro has not been
reported. This may re¯ect that the active recruitment of
XRCC1 to breaks is not required for repair in simple cell-free
reactions, because the high concentration of DNA breaks and
soluble repair factors in such experiments prevent the
detection of DNA breaks from being a rate limiting step.
However, active recruitment of XRCC1 and its protein
partners may be important to accelerate the detection and
repair of SSBs within the context of the nuclear genome, in
which DNA breaks are relatively rare and distributed amongst
many kilobases of undamaged DNA. It is also possible that the
recruitment of XRCC1 is important for repair of chromatin,
rather than naked plasmid DNA or oligonucleotide duplex.
We have suggested that PARP-1 may primarily be required
to recruit XRCC1 to direct DNA breaks, which are `un-
scheduled' and require rapid detection (31). It is feasible that
PARP-1 also recruits XRCC1 to SSBs arising during BER,
since both PAR and XRCC1 foci were absent from Parp1±/±
MEFs after exposure to the alkylating agent, MMS. However,
it is more dif®cult to envisage a need for PARP to `detect'
breaks during early stages of BER, since current models
suggest that breaks created by APE1 can be passed directly to
DNA polymerase b (38±40) which in turn may itself then
recruit XRCC1/DNA ligase IIIa for the completion of DNA
repair (13,14,31). Perhaps PAR synthesis after base damage
re¯ects binding by PARP-1 to SSBs at a later stage of BER,
since PARP-1 may in¯uence the choice of whether short patch
or long patch repair is employed during DNA gap ®lling
(23,35,41,42). Alternatively, PAR synthesis after base damage
could re¯ect a fraction of abasic sites that become `uncoupled'
from APE1 after cleavage or that are cleaved by an AP lyase
activity, either of which might be expected to result in
`exposed' SSBs that require rapid detection by PARP-1.
In summary, these data show that PARP-1 is required for
assembly or stability of XRCC1 nuclear foci after oxidative
DNA damage, consistent with a model in which poly (ADP-
ribose) synthesis serves to recruit XRCC1 to sites of DNA
strand breakage.
ACKNOWLEDGEMENTS
S.E.K. is funded by an MRC Programme Grant (G0001259) to
K.W.C. We thank Gilbert de Murcia for the gift of anti-PAR
antibodies.
REFERENCES
1. Xu,Y.J., Kim,E.Y. and Demple,B. (1998) Excision of C-4¢-oxidized
deoxyribose lesions from double-stranded DNA by human apurinic/
apyrimidinic endonuclease (Ape1 protein) and DNA polymerase beta.
J. Biol. Chem., 273, 28837±28844.
2. Caldecott,K.W. (2001) Mammalian DNA single-strand break repair:
an X-ra(y)ted affair. Bioessays, 23, 447±455.
3. Ochs,K., Sobol,R.W., Wilson,S.H. and Kaina,B. (1999) Cells de®cient in
DNA polymerase beta are hypersensitive to alkylating agent-induced
apoptosis and chromosomal breakage. Cancer Res., 59, 1544±1551.
4. Thompson,L.H., Brookman,K.W., Dillehay,L.E., Carrano,A.V.,
Mazrimas,J.A., Mooney,C.L. and Minkler,J.L. (1982) A CHO-cell strain
having hypersensitivity to mutagens, a defect in DNA strand-break
repair, and an extraordinary baseline frequency of sister-chromatid
exchange. Mutat. Res., 95, 427±440.
5. Dominguez,I., Daza,P., Natarajan,A.T. and Cortes,F. (1998) A high yield
of translocations parallels the high yield of sister chromatid exchanges in
the CHO mutant EM9. Mutat. Res., 398, 67±73.
6. Oph,V., Zdzienicka,M.Z., Vrieling,H., Lohman,P.H. and van
Zeeland,A.A. (1994) Molecular analysis of ethyl methanesulfonate-
induced mutations at the hprt gene in the ethyl methanesulfonate-
sensitive Chinese hamster cell line EM-C11 and its parental line CHO9.
Cancer Res., 54, 3001±3006.
7. Zdzienicka,M.Z., Vanderschans,G.P., Natarajan,A.T., Thompson,L.H.,
Neuteboom,I. and Simons,J.W.I.M. (1992) A Chinese-hamster ovary cell
mutant (Em-c-11) with sensitivity to simple alkylating-agents and a very
high-level of sister chromatid exchanges. Mutagenesis, 7, 265±269.
8. Kuzminov,A. (2001) Single-strand interruptions in replicating
chromosomes cause double-strand breaks. Proc. Natl Acad. Sci. USA, 98,
8241±8246.
5532 Nucleic Acids Research, 2003, Vol. 31, No. 19
 at U






9. Thompson,L.H. and West,M.G. (2000) XRCC1 keeps DNA from getting
stranded. Mutat. Res., 459, 1±18.
10. Tebbs,R.S., Flannery,M.L., Meneses,J.J., Hartmann,A., Tucker,J.D.,
Thompson,L.H., Cleaver,J.E. and Pedersen,R.A. (1999) Requirement for
the Xrcc1 DNA base excision repair gene during early mouse
development. Dev. Biol., 208, 513±529.
11. Whitehouse,C.J., Taylor,R.M., Thistlethwaite,A., Zhang,H.,
Karimi-Busheri,F., Lasko,D.D., Weinfeld,M. and Caldecott,K.W. (2001)
XRCC1 stimulates human polynucleotide kinase activity at damaged
DNA termini and accelerates DNA single-strand break repair. Cell, 104,
107±117.
12. Vidal,A.E., Boiteux,S., Hickson,I.D. and Radicella,J.P. (2001) XRCC1
coordinates the initial and late stages of DNA abasic site repair through
protein±protein interactions. EMBO J., 20, 6530±6539.
13. Caldecott,K.W., Aoufouchi,S., Johnson,P. and Shall,S. (1996) XRCC1
polypeptide interacts with DNA polymerase beta and possibly poly
(ADP-ribose) polymerase, and DNA ligase III is a novel molecular
`nick-sensor' in vitro. Nucleic Acids Res., 24, 4387±4394.
14. Kubota,Y., Nash,R.A., Klungland,A., Schar,P., Barnes,D.E. and
Lindahl,T. (1996) Reconstitution of DNA base excision-repair with
puri®ed human proteins: interaction between DNA polymerase beta and
the XRCC1 protein. EMBO J., 15, 6662±6670.
15. Mackey,Z.B., Ramos,W., Levin,D.S., Walter,C.A., Mccarrey,J.R. and
Tomkinson,A.E. (1997) An alternative splicing event which occurs in
mouse pachytene spermatocytes generates a form of DNA ligase III with
distinct biochemical properties that may function in meiotic
recombination. Mol. Cell. Biol., 17, 989±998.
16. Nash,R.A., Caldecott,K.W., Barnes,D.E. and Lindahl,T. (1997) XRCC1
protein interacts with one of two distinct forms of DNA ligase III.
Biochemistry, 36, 5207±5211.
17. Caldecott,K.W., Tucker,J.D., Stanker,L.H. and Thompson,L.H. (1995)
Characterization of the XRCC1-DNA ligase III complex in vitro and its
absence from mutant hamster cells. Nucleic Acids Res., 23, 4836±4843.
18. Caldecott,K.W., Mckeown,C.K., Tucker,J.D., Ljungquist,S. and
Thompson,L.H. (1994) An interaction between the mammalian DNA
repair protein XRCC1 and DNA ligase III. Mol. Cell. Biol., 14, 68±76.
19. Masson,M., Niedergang,C., Schreiber,V., Muller,S., Menissier-de
Murcia,J. and de Murcia,G. (1998) XRCC1 is speci®cally associated with
poly(ADP-ribose) polymerase and negatively regulates its activity
following DNA damage. Mol. Cell. Biol., 18, 3563±3571.
20. Burkle,A. (2001) Physiology and pathophysiology of poly(ADP-
ribosyl)ation. Bioessays, 23, 795±806.
21. Shall,S. and De Murcia,G. (2000) Poly(ADP-ribose) polymerase-1: what
have we learned from the de®cient mouse model? Mutat. Res., 460, 1±15.
22. Pleschke,J.M., Kleczkowska,H.E., Strohm,M. and Althaus,F.R. (2000)
Poly(ADP-ribose) binds to speci®c domains in DNA damage checkpoint
proteins. J. Biol. Chem., 275, 40974±40980.
23. Dantzer,F., de La,R.G., Menissier-de Murcia,J., Hostomsky,Z., De
Murcia,G. and Schreiber,V. (2000) Base excision repair is impaired in
mammalian cells lacking poly(ADP-ribose) polymerase-1. Biochemistry,
39, 7559±7569.
24. Schreiber,V., Ame,J.C., Dolle,P., Schultz,I., Rinaldi,B., Fraulob,V.,
Menissier-de Murcia,J. and De Murcia,G. (2002) Poly(ADP-ribose)
polymerase-2 (PARP-2) is required for ef®cient base excision DNA
repair in association with PARP-1 and XRCC1. J. Biol. Chem., 277,
23028±23036.
25. Taylor,R.M., Thistlethwaite,A. and Caldecott,K.W. (2002) Central role
for the XRCC1 BRCT I domain in mammalian DNA single-strand break
repair. Mol. Cell. Biol., 22, 2556±2563.
26. Masutani,M., Suzuki,H., Kamada,N., Watanabe,M., Ueda,O., Nozaki,T.,
Jishage,K., Watanabe,T., Sugimoto,T., Nakagama,H. et al. (1999)
Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to
streptozotocin-induced diabetes. Proc. Natl Acad. Sci. USA, 96,
2301±2304.
27. Kadkhodayan,S., Salazar,E.P., Lamerdin,J.E. and Weber,C.A. (1996)
Construction of a functional cDNA clone of the hamster ERCC2 DNA
repair and transcription gene. Somat. Cell Mol. Genet., 22, 453±460.
28. Kubota,Y. and Horiuchi,S. (2003) Independent roles of XRCC1's two
BRCT motifs in recovery from methylation damage. DNA Repair
(Amst.), 2, 407±415.
29. Masutani,M., Nozaki,T., Nakamoto,K., Nakagama,H., Suzuki,H.,
Kusuoka,O., Tsutsumi,M. and Sugimura,T. (2000) The response of Parp
knockout mice against DNA damaging agents. Mutat. Res., 462,
159±166.
30. Herceg,Z. and Wang,Z.Q. (2001) Functions of poly(ADP-ribose)
polymerase (PARP) in DNA repair, genomic integrity and cell death.
Mutat. Res., 477, 97±110.
31. Caldecott,K.W. (2003) DNA single-strand break repair and
spinocerebellar ataxia. Cell, 112, 7±10.
32. Nocentini,S. (1999) Rejoining kinetics of DNA single- and double-strand
breaks in normal and DNA ligase-de®cient cells after exposure to
ultraviolet C and gamma radiation: An evaluation of ligating activities
involved in different DNA repair processes. Radiat. Res., 151, 423±432.
33. Taylor,R.M., Moore,D.J., Whitehouse,J., Johnson,P. and Caldecott,K.W.
(2000) A cell cycle-speci®c requirement for the XRCC1 BRCT II domain
during mammalian DNA strand break repair. Mol. Cell. Biol., 20,
735±740.
34. Moore,D.J., Taylor,R.M., Clements,P. and Caldecott,K.W. (2000)
Mutation of a BRCT domain selectively disrupts DNA single-strand
break repair in noncycling Chinese hamster ovary cells. Proc. Natl Acad.
Sci. USA, 97, 13649±13654.
35. Sanderson,R.J. and Lindahl,T. (2002) Down-regulation of DNA repair
synthesis at DNA single-strand interruptions in poly(ADP-ribose)
polymerase-1 de®cient murine cell extracts. DNA Repair (Amst.), 1,
547±558.
36. Simbulan-Rosenthal,C.M., Ly,D.H., Rosenthal,D.S., Konopka,G.,
Luo,R., Wang,Z.Q., Schultz,P.G. and Smulson,M.E. (2000)
Misregulation of gene expression in primary ®broblasts lacking
poly(ADP-ribose) polymerase. Proc. Natl Acad. Sci. USA, 97,
11274±11279.
37. Tulin,A. and Spradling,A. (2003) Chromatin loosening by poly(ADP)-
ribose polymerase (PARP) at Drosophila puff loci. Science, 299,
560±562.
38. Bennett,R.A., Wilson,D.M.,III, Wong,D. and Demple,B. (1997)
Interaction of human apurinic endonuclease and DNA polymerase beta in
the base excision repair pathway. Proc. Natl Acad. Sci. USA, 94,
7166±7169.
39. Wilson,S.H. and Kunkel,T.A. (2000) Passing the baton in base excision
repair. Nat. Struct. Biol., 7, 176±178.
40. Mol,C.D., Izumi,T., Mitra,S. and Tainer,J.A. (2000) DNA-bound
structures and mutants reveal abasic DNA binding by APE1 and DNA
repair coordination [corrected]. Nature, 403, 451±456.
41. Prasad,R., Lavrik,O.I., Kim,S.J., Kedar,P., Yang,X.P., Vande Berg,B.J.
and Wilson,S.H. (2001) DNA polymerase beta-mediated long patch base
excision repair. Poly(ADP-ribose)polymerase-1 stimulates strand
displacement DNA synthesis. J. Biol. Chem., 276, 32411±32414.
42. Le Page,F., Schreiber,V., Dherin,C., De Murcia,G. and Boiteux,S. (2003)
Poly(ADP-ribose) polymerase-1(PARP-1) is required in murine cell lines
for base excision repair of oxidative DNA damage in absence of DNA
polymerase beta. J. Biol. Chem., 278, 18471±18477.
Nucleic Acids Research, 2003, Vol. 31, No. 19 5533
 at U
niversity of Sussex on June 18, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
